ASX:ECS

ECS Botanics (ECS) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.99 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.22%
Price Target
N/A
ECS stock logo

About ECS Botanics Stock (ASX:ECS)

ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. The company is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.

ECS Stock News Headlines

He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
ECS Botanics Holdings Ltd ECS
He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Brooklyn Botanic Garden
ECS.AX - | Stock Price & Latest News | Reuters
See More Headlines
Receive ECS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ECS Botanics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$2.49 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$19.87 million
Book Value
A$0.02 per share

Miscellaneous

Outstanding Shares
1,290,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.27
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Ms. Nan-Maree Schoerie Dip Chem
    MD & Executive Director
  • Mr. Alexander Keach
    Founder & Non-Executive Director
  • Ms. Nikki Cranley
    Financial Controller
  • Mr. Arthur Sun
    Financial Controller
  • Mr. Jason Hine
    Chief Operations Officer
  • Ms. Sally Allport
    Executive Assistant to MD & Marketing Manager
  • Mr. Michael Clark
    Head of European Operations
  • Mr. Mauro Piccini
    Company Secretary

This page (ASX:ECS) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners